Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APREPITANT Cause Product use issue? 323 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 323 reports of Product use issue have been filed in association with APREPITANT (CINVANTI). This represents 5.8% of all adverse event reports for APREPITANT.

323
Reports of Product use issue with APREPITANT
5.8%
of all APREPITANT reports
122
Deaths
282
Hospitalizations

How Dangerous Is Product use issue From APREPITANT?

Of the 323 reports, 122 (37.8%) resulted in death, 282 (87.3%) required hospitalization, and 169 (52.3%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 323 reports have been filed with the FAERS database.

What Other Side Effects Does APREPITANT Cause?

Fatigue (955) Pyrexia (913) Dyspnoea (909) Hypersensitivity (881) Rash (789) Alopecia (760) Gastrointestinal disorder (722) Pruritus (707) Confusional state (696) Glossodynia (696)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which APREPITANT Alternatives Have Lower Product use issue Risk?

APREPITANT vs APROTININ APREPITANT vs ARANESP APREPITANT vs ARAVA APREPITANT vs AREDIA APREPITANT vs ARFORMOTEROL

Related Pages

APREPITANT Full Profile All Product use issue Reports All Drugs Causing Product use issue APREPITANT Demographics